Intra-Cellular Therapies Company Profile (NASDAQ:ITCI)

About Intra-Cellular Therapies

Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company's pipeline includes approximately two product candidates in clinical development and two product candidates in advanced pre-clinical testing. Its platform includes ITI-007 platform and phosphodiesterase (PDE) Inhibitor Platform. It is developing its lead drug candidate, ITI-007, for the treatment of schizophrenia, behavioral disturbances associated with dementia, autism and other CNS diseases. Its ITI-007 platform also includes long acting injectable (LAI) program, and IC200131 program for mood and other disorders. Its PDE Inhibitor Platform includes PDE1 program and PDE2 and PDE9 programs.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Exchange: NASDAQ
• Symbol: ITCI
• CUSIP:

Key Metrics:

• Previous Close: $42.35
• 50 Day Moving Average: $41.73
• 200 Day Moving Average: $37.37
• 52-Week Range: $22.41 - $59.96
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -13.89
• P/E Growth: 0.00
• Market Cap: $1.83B
• Outstanding Shares: 43,251,000
• Beta: 0.81

Profitability:

• Return on Equity: -25.78%
• Return on Assets: -25.08%

Debt:

• Current Ratio: 23.06%
• Quick Ratio: 23.05%

Additional Links:

• Visit Intra-Cellular Therapies' Official Website
• View ITCI on Google Finance
• View ITCI on Yahoo Finance
• View ITCI's Company Profile on Reuters
• Search for Intra-Cellular Therapies Inc. on Google

Companies Related to Intra-Cellular Therapies:

• Amsurg Corp. (NASDAQ:AMSG)
• Akorn (NASDAQ:AKRX)
• PRA Health Sciences (NASDAQ:PRAH)
• China Biologic Products (NASDAQ:CBPO)
• NuVasive (NASDAQ:NUVA)
• Cantel Medical Corp. (NYSE:CMN)
• Molina Healthcare (NYSE:MOH)
• Intrexon Corp. (NYSE:XON)
• Brookdale Senior Living (NYSE:BKD)
• Catalent (NYSE:CTLT)

Earnings

Earnings History for Intra-Cellular Therapies (NASDAQ:ITCI)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/3/2016
8/4/2016	Q216	($0.79)	($0.71)	$0.02 million	$0.23 million	View	N/A
4/28/2016	Q116	($0.78)	($0.64)	$0.02 million		View	Listen
2/25/2016	Q415	($0.87)	($0.67)	$0.05 million	$30.66 million	View	Listen
11/5/2015	Q315	($0.66)	($0.91)			View	N/A
8/5/2015	Q215	($0.72)	($0.61)	$40.00 million	$57.40 million	View	N/A
4/30/2015	Q1	($0.68)	($0.72)			View	N/A
3/12/2015		($0.49)	($0.52)			View	N/A
11/3/2014	Q314	($0.28)	($0.22)			View	N/A
8/12/2014	Q214	($0.23)	($0.15)			View	N/A
5/8/2014		($0.23)	($0.17)			View	N/A
3/26/2014		($0.41)	($0.36)			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intra-Cellular Therapies (NASDAQ:ITCI)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	2	($0.74)	($0.63)	($0.69)
Q2 2016	2	($0.79)	($0.65)	($0.72)
Q3 2016	3	($0.82)	($0.66)	($0.71)
Q4 2016	1	($0.93)	($0.93)	($0.93)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Intra-Cellular Therapies (NASDAQ:ITCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intra-Cellular Therapies (NASDAQ:ITCI)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
2/29/2016	Christopher D Alafi	Director	Buy	100,000	$29.70	$2,970,000.00
12/15/2015	Lawrence J. Hineline	CFO	Sell	45,000	$51.45	$2,315,250.00
12/11/2015	Sharon Mates	CEO	Sell	51,500	$53.87	$2,774,305.00
12/8/2015	Joel S Marcus	Director	Sell	92,700	$54.47	$5,049,369.00
11/24/2015	Lawrence J Hineline	CFO	Sell	5,000	$55.00	$275,000.00
6/8/2015	Lawrence P Wennogle	VP	Sell	25,000	$26.84	$671,000.00
3/11/2015	Christopher D Alafi	Director	Buy	625,000	$24.00	$15,000,000.00
12/9/2014	Lawrence J Hineline	CFO	Sell	22,500	$16.71	$375,975.00
12/1/2014	Moshe Alafi	Major Shareholder	Buy	1,422	$14.75	$20,974.50
11/28/2014	Christopher D Alafi	Director	Buy	35,000	$14.75	$516,250.00
11/19/2014	Alafi Capital Co Llc	Major Shareholder	Buy	1,034	$14.25	$14,734.50
11/18/2014	Alafi Capital Co Llc	Major Shareholder	Buy	3,664	$14.26	$52,248.64
11/13/2014	Alafi Capital Co Llc	Major Shareholder	Buy	12,200	$15.34	$187,148.00
11/6/2014	Michael Halstead	SVP	Buy	20,000	$15.38	$307,600.00
10/15/2014	Lawrence P Wennogle	VP	Sell	3,604	$15.00	$54,060.00
10/13/2014	Lawrence P Wennogle	VP	Sell	1,600	$15.00	$24,000.00
10/8/2014	Lawrence P Wennogle	VP	Sell	4,745	$15.00	$71,175.00
10/6/2014	Lawrence P Wennogle	VP	Sell	16,499	$15.00	$247,485.00
9/15/2014	Lawrence P Wennogle	VP	Sell	5,000	$15.00	$75,000.00
9/8/2014	Lawrence J Hineline	CFO	Sell	300	$15.00	$4,500.00
5/22/2014	Lawrence P Wennogle	VP	Sell	6,000	$15.00	$90,000.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Intra-Cellular Therapies (NASDAQ:ITCI)

Date	Headline
	Noteworthy Tuesday Option Activity: GOOGL, ITCI, N - Forbes (NASDAQ:ITCI) www.forbes.com - September 28 at 5:30 PM
	Intra-Cellular Therapies (ITCI) Announces ITI-007 Phase 3 Missed Primary Endpoint in Schizophrenia - StreetInsider.com (NASDAQ:ITCI) www.streetinsider.com - September 28 at 5:30 PM
	Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Is Expected To Post EPS Of $-0.95 - RealistInvestor.com (NASDAQ:ITCI) www.realistinvestor.com - September 28 at 5:30 PM
	INTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:ITCI) biz.yahoo.com - September 28 at 5:30 PM
	Intra-Cellular Therapies shares halted (NASDAQ:ITCI) www.marketwatch.com - September 28 at 5:30 PM
	Intra-Cellular Therapies Announces Top-Line Results from the Second Phase 3 Trial of ITI-007 in Patients with Schizophrenia (Study ‘302) (NASDAQ:ITCI) www.publicnow.com - September 28 at 5:30 PM
	Intra-Cellular Therapies shares plunge 68% after study results (NASDAQ:ITCI) www.marketwatch.com - September 28 at 5:30 PM
	[$$] Intra-Cellular Therapies Shares Plunge After Disappointing Drug Trial Results (NASDAQ:ITCI) www.wsj.com - September 28 at 5:30 PM
	Intra-Cellular Therapies, Inc. breached its 50 day moving average in a Bullish Manner : ITCI-US : September 26, 2016 (NASDAQ:ITCI) www.capitalcube.com - September 26 at 10:20 AM
	Shares Of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Expected To Hit $95 - Investor Newswire (NASDAQ:ITCI) www.investornewswire.com - September 22 at 3:51 PM
	Stock to keep an eye on: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Theriponadvance.com (NASDAQ:ITCI) theriponadvance.com - September 22 at 3:51 PM
	Intra-Cellular Therapies, Inc.'s (ITCI): Stock Analysis Review - Hot Stocks Point (NASDAQ:ITCI) www.hotstockspoint.com - September 22 at 3:51 PM
	Allergan pays top dollar for 'stepping stones' from neurology to dermatolo... - Reuters (NASDAQ:ITCI) www.reuters.com - September 20 at 10:48 AM
	Piper Jaffray Begins Coverage on Intra-Cellular Therapies Inc (ITCI) - DailyQuint (NASDAQ:ITCI) dailyquint.com - September 17 at 10:14 AM
	Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Posted A Surprise Factor Of 10.13 Percent - Investor Newswire (NASDAQ:ITCI) www.investornewswire.com - September 15 at 6:08 PM
	Can Shares Of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Hit $95 - Investor Newswire (NASDAQ:ITCI) www.investornewswire.com - September 15 at 8:55 AM
	Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Is Expected To Post ... - RealistInvestor.com (NASDAQ:ITCI) www.realistinvestor.com - September 14 at 5:49 PM
	3 All-or-Nothing Biotechs I'm Watching Like a Hawk (NASDAQ:ITCI) www.fool.com - September 12 at 10:26 AM
	Placing Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Shares Under the Microscope - Post News (NASDAQ:ITCI) www.kentuckypostnews.com - September 9 at 5:29 PM
	Intra-Cellular Therapies, Inc. – Value Analysis (NASDAQ:ITCI) : September 8, 2016 (NASDAQ:ITCI) www.capitalcube.com - September 8 at 5:36 PM
	Stock Sliding Down Over the Last Month: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Post News (NASDAQ:ITCI) www.kentuckypostnews.com - September 8 at 9:37 AM
	Intra-Cellular Therapies, Inc. breached its 50 day moving average in a Bullish Manner : ITCI-US : September 7, 2016 (NASDAQ:ITCI) www.capitalcube.com - September 7 at 9:09 AM
	Can Shares Of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Get To $95? - Investor Newswire (NASDAQ:ITCI) www.investornewswire.com - September 3 at 10:12 AM
	BRIEF-Intra-Cellular Therapies files for mixed shelf of up to $350 mln (NASDAQ:ITCI) feeds.reuters.com - September 2 at 6:46 PM
	ETF’s with exposure to Intra-Cellular Therapies, Inc. : August 29, 2016 (NASDAQ:ITCI) www.capitalcube.com - August 29 at 5:35 PM
	Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ITCI) www.investornewswire.com - August 26 at 5:34 PM
	Intra-Cellular Therapies, Inc. breached its 50 day moving average in a Bearish Manner : ITCI-US : August 26, 2016 (NASDAQ:ITCI) www.capitalcube.com - August 26 at 8:41 AM
	Crowd is Weighing in on Intra-Cellular Therapies Inc. (NASDAQ:ITCI) - Post News (NASDAQ:ITCI) www.kentuckypostnews.com - August 21 at 5:12 PM
	ETF’s with exposure to Intra-Cellular Therapies, Inc. : August 18, 2016 (NASDAQ:ITCI) www.capitalcube.com - August 19 at 8:42 AM
	Will Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Hit $95 Price Target? - Investor Newswire (NASDAQ:ITCI) www.investornewswire.com - August 18 at 5:44 PM
	Analysts See Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Reporting EPS Of $-0.95 - RealistInvestor.com (NASDAQ:ITCI) www.realistinvestor.com - August 18 at 5:44 PM
	INTRA-CELLULAR THERAPIES, INC. Financials (NASDAQ:ITCI) finance.yahoo.com - August 12 at 5:49 PM
	Intra-Cellular Therapies Inc. (ITCI) is Trading Higher on Unusual Volume for August 08 - Equities.com (NASDAQ:ITCI) www.equities.com - August 10 at 8:37 AM
	Notable Analyst Coverage: SUPERVALU INC. (NYSE:SVU), Intra-Cellular Therapies Inc (NASDAQ:ITCI) - Review Fortune (NASDAQ:ITCI) reviewfortune.com - August 9 at 5:53 PM
	Biggest Healthcare Movers: Exact Sciences Corporation (NASDAQ:EXAS), Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - TWN (NASDAQ:ITCI) thewellesleysnews.com - August 9 at 5:53 PM
	ETF’s with exposure to Intra-Cellular Therapies, Inc. : August 8, 2016 (NASDAQ:ITCI) www.capitalcube.com - August 8 at 5:54 PM
	Noteworthy Friday Option Activity: CPSI, BA, ITCI (NASDAQ:ITCI) www.marketnewsvideo.com - August 6 at 8:36 AM
	Intra-Cellular Therapies, Inc. :ITCI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:ITCI) www.capitalcube.com - August 5 at 5:52 PM
	Intra-Cellular reports 2Q loss (NASDAQ:ITCI) sg.finance.yahoo.com - August 4 at 6:01 PM
	7:06 am Intra-Cellular Therapies beats by $0.08, beats on revs (NASDAQ:ITCI) finance.yahoo.com - August 4 at 8:46 AM
	INTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Finan (NASDAQ:ITCI) biz.yahoo.com - August 4 at 8:46 AM
	Intra-Cellular Therapies Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:ITCI) www.publicnow.com - August 4 at 8:46 AM
	Can Shares Of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Hit $95? - Investor Newswire (NASDAQ:ITCI) www.investornewswire.com - July 28 at 8:44 AM
	Intra-Cellular Therapies to Host Second Quarter 2016 Financial Results Conference Call and Webcast (NASDAQ:ITCI) www.publicnow.com - July 25 at 8:18 AM
	Were Analysts Bearish Intra-Cellular Therapies Inc (NASDAQ:ITCI) This Week? - Consumer Eagle (NASDAQ:ITCI) www.consumereagle.com - July 22 at 5:38 PM
	Intra-Cellular Therapies Inc (NASDAQ:ITCI) Stock Technicals Hit Strength - CML News (NASDAQ:ITCI) news.cmlviz.com - July 22 at 5:38 PM
	Shares Positive Over the Past Month: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - TGP (NASDAQ:ITCI) telanaganapress.com - July 20 at 8:43 AM
	Equity Roundup: Stock Performance Focus on Intra-Cellular Therapies Inc. (NASDAQ:ITCI) - Press Telegraph (NASDAQ:ITCI) presstelegraph.com - July 19 at 11:49 AM
	Stock in Positive Territory for the Quarter: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Engelwood Daily (NASDAQ:ITCI) www.engelwooddaily.com - July 18 at 5:53 PM
	Shares Experiencing a Downtrend: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - TGP (NASDAQ:ITCI) telanaganapress.com - July 17 at 5:15 PM

Social

Intra-Cellular Therapies (NASDAQ:ITCI) Chart for Wednesday, September, 28, 2016